Projected Income Statement: Exelon Corporation

Forecast Balance Sheet: Exelon Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 38,670 41,235 39,077 43,563 46,292 50,103 54,024 57,103
Change - 6.63% -5.23% 11.48% 6.26% 8.23% 7.83% 5.7%
Announcement Date 2/24/21 2/25/22 2/14/23 2/21/24 2/12/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: Exelon Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 8,048 7,981 7,147 7,408 7,097 8,940 9,605 9,639
Change - -0.83% -10.45% 3.65% -4.2% 25.96% 7.44% 0.35%
Free Cash Flow (FCF) 1 -3,813 -4,969 -2,277 -2,705 -1,528 -62 -853 -248
Change - -30.32% 54.18% -18.8% 43.51% 95.94% -1,275.81% 70.93%
Announcement Date 2/24/21 2/25/22 2/14/23 2/21/24 2/12/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Exelon Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 25.65% 23.55% 34.81% 34.65% 34.36% 36.12% 37.5% 38.9%
EBIT Margin (%) 13.32% 6.94% 17.39% 18.52% 18.76% 20.78% 21.49% 22.32%
EBT Margin (%) 7.06% 6.07% 12.6% 12.44% 11.58% 13.21% 13.57% 14.08%
Net margin (%) 5.94% 4.69% 11.37% 10.71% 10.68% 11.21% 11.57% 12.15%
FCF margin (%) -11.54% -13.67% -11.94% -12.45% -6.64% -0.26% -3.39% -0.95%
FCF / Net Income (%) -194.24% -291.27% -104.93% -116.19% -62.11% -2.28% -29.28% -7.85%

Profitability

        
ROA 2.48% 2.11% 1.9% 2.36% 2.35% 2.54% 2.59% 2.61%
ROE 9.72% 8.25% 7.34% 9.41% 9.34% 9.84% 9.82% 9.91%

Financial Health

        
Leverage (Debt/EBITDA) 4.56x 4.82x 5.88x 5.79x 5.85x 5.72x 5.72x 5.64x
Debt / Free cash flow -10.14x -8.3x -17.16x -16.1x -30.3x -808.12x -63.33x -230.25x

Capital Intensity

        
CAPEX / Current Assets (%) 24.36% 21.96% 37.46% 34.1% 30.82% 36.84% 38.14% 37.06%
CAPEX / EBITDA (%) 94.95% 93.26% 107.6% 98.39% 89.69% 101.99% 101.72% 95.26%
CAPEX / FCF (%) -211.07% -160.62% -313.88% -273.86% -464.46% -14,418.55% -1,125.98% -3,886.53%

Items per share

        
Cash flow per share 1 4.335 3.073 - 4.717 5.552 6.256 6.577 -
Change - -29.1% - - 17.7% 12.67% 5.13% -
Dividend per Share 1 1.53 1.53 1.35 1.44 1.52 1.602 1.688 1.779
Change - 0% -11.76% 6.67% 5.56% 5.4% 5.35% 5.42%
Book Value Per Share 1 33.39 35.13 - 25.78 26.84 28.23 29.55 30.97
Change - 5.23% - - 4.11% 5.18% 4.68% 4.78%
EPS 1 2.01 1.74 2.19 2.34 2.45 2.72 2.859 3.057
Change - -13.43% 25.86% 6.85% 4.7% 11.02% 5.11% 6.91%
Nbr of stocks (in thousands) 975,572 978,318 993,742 995,437 1,004,834 1,010,290 1,010,290 1,010,290
Announcement Date 2/24/21 2/25/22 2/14/23 2/21/24 2/12/25 - - -
1USD
Estimates
2025 *2026 *
P/E ratio 16.1x 15.3x
PBR 1.55x 1.48x
EV / Sales 3.89x 3.9x
Yield 3.66% 3.86%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
43.76USD
Average target price
49.31USD
Spread / Average Target
+12.69%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EXC Stock
  4. Financials Exelon Corporation